QUIDELORTHO CORP Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
QUIDELORTHO CORP (QDEL) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of -$15.40 million as of 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-02-19
- 2025-12-28: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$15.40M.
- 2025-03-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$23.80M.
- 2024-12-29: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$36.20M.
- 2024-09-29: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$3.50M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2025-12-28 | -$15.40M 10-K · filed 2026-02-19 |
| 2025-03-30 | -$23.80M 10-Q · filed 2025-05-08 |
| 2024-12-29 | -$36.20M 10-K · filed 2026-02-19 |
| 2024-09-29 | -$3.50M 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$24.60M 10-Q · filed 2024-11-08 |
| 2024-03-31 | -$26.20M 10-Q · filed 2025-05-08 |
| 2023-12-31 | -$30.00M 10-K · filed 2026-02-19 |
| 2023-10-01 | -$53.20M 10-Q · filed 2024-11-08 |
| 2023-07-02 | -$16.30M 10-Q · filed 2024-11-08 |
| 2023-04-02 | -$59.30M 10-Q · filed 2024-08-01 |
| 2023-01-01 | -$67.60M 10-K · filed 2026-02-19 |
| 2022-10-02 | -$144.50M 10-Q · filed 2023-11-02 |
| 2022-07-03 | -$60.70M 10-Q · filed 2023-11-02 |
| 2022-04-03 | $200.00K 10-Q · filed 2023-08-09 |
| 2022-01-02 | $400.00K 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |